EXPLORE OUR CLINICAL TRIALS AT ACC.19

CLINICAL TRIALS

Evolut Bicuspid Low-Risk Clinical Study
NOW ENROLLING



Evolut Low Risk Continued Access Study

Image of Evolut TAVR Platform

Evolut™
TAVR Platform


DESTINATION THERAPY (DT) POST-APPROVAL STUDY (PAS) NOW ENROLLING IN THE UNITED STATES

To further confirm safety and effectiveness of the Medtronic HeartWare™ HVAD™ system when used as intended for DT in real-world clinical practice.

HeartWare™ HVAD™ System

HeartWare™ HVAD™
System


APOGEE Trial:
NOW ENROLLING IN THE US

A post-approval on-label study to further enhance scientific understanding of the implant procedure, optimized blood pressure management, and anticoagulation/ antiplatelet therapy in patients receiving an HVAD for DT. Patients participating in DT PAS are eligible for co-enrollment in Apogee.

 

APOGEE Trial

APOLLO TRIAL
NOW ENROLLING

Explore clinical trial options for patients with severe mitral regurgitation.

Image of Intrepid TMVR System

Intrepid™
Transcatheter Mitral Valve Replacement
(TMVR) System

CAUTION: Investigational device. Limited by federal law (USA) to investigational use. Exclusively for clinical investigation.


ONYX ONE
DAPT PROGRAM

Committed to advancing DAPT evidence in high-bleeding risk patients with Resolute Onyx™ DES.

Image of Resolute Onyx DES

Resolute Onyx™ DES
Zotarolimus-eluting Coronary Stent System


SPYRAL HTN CLINICAL PROGRAM
NOW ENROLLING

  • USA
  • Canada
  • Europe
  • Japan
  • Australia
Image of Symplicity Spyral Catheter

Symplicity Spyral™
Multi-electrode Renal Denervation Catheter

Caution: Investigational device. Limited by federal law (USA) to investigational use in the USA and Japan. Exclusively for clinical investigation.


©2019 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. For distribution in the USA only.